BLOG | Alphawatch

top of page

August M&A Activity and Details

August M&A Activity and Details

August M&A Activity and Details

Biotech & Healthcare

Jonathan Poyer

Sep 9, 20241 min read

Biotech Markets Pricing in Rate Cuts as Index Stays Above 50-Day Average.

Biotech Markets Pricing in Rate Cuts as Index Stays Above 50-Day Average.

Biotech Markets Pricing in Rate Cuts as Index Stays Above 50-Day Average.

Biotech/Healthcare Weekly Updates

Jonathan Poyer

Sep 4, 20243 min read

August 2024 Follow-Up with the Doctor

August 2024 Follow-Up with the Doctor

August 2024 Follow-Up with the Doctor

Dr. is IN Monthly Call Recordings

Jonathan Poyer

Aug 31, 20241 min read

Record Low Volumes but Biotech Catching a Tailwind with Expectations of Rate Cuts

Record Low Volumes but Biotech Catching a Tailwind with Expectations of Rate Cuts

Record Low Volumes but Biotech Catching a Tailwind with Expectations of Rate Cuts

Biotech & Healthcare

Jonathan Poyer

Aug 29, 20241 min read

Low Trading Volume Reflects Wait and See Approach to Rates, Market Volatility

Low Trading Volume Reflects Wait and See Approach to Rates, Market Volatility

Low Trading Volume Reflects Wait and See Approach to Rates, Market Volatility

Biotech & Healthcare

Jonathan Poyer

Aug 23, 20242 min read

Biotech Capital Markets Highlights: Transactions 2X Over 2023

Biotech Capital Markets Highlights: Transactions 2X Over 2023

Biotech Capital Markets Highlights: Transactions 2X Over 2023

Biotech & Healthcare

Jonathan Poyer

Aug 20, 20241 min read

August 2024 Riffin' on Real Estate

August 2024 Riffin' on Real Estate

August 2024 Riffin' on Real Estate

Jonathan Poyer

Aug 19, 20241 min read

Government Announces Drug Price Controls

Government Announces Drug Price Controls

Government Announces Drug Price Controls

Biotech & Healthcare

Jonathan Poyer

Aug 16, 20241 min read

Earnings Season Continues with Beats. Market Poised for a Breakout but Appears Waiting on Rates

Earnings Season Continues with Beats. Market Poised for a Breakout but Appears Waiting on Rates

Earnings Season Continues with Beats. Market Poised for a Breakout but Appears Waiting on Rates

Biotech & Healthcare

Jonathan Poyer

Aug 15, 20242 min read

Biotech Stays Above 50-Day Moving Average and Crown Therapeutics Acquires Revance for $924M

Biotech Stays Above 50-Day Moving Average and Crown Therapeutics Acquires Revance for $924M

Biotech Stays Above 50-Day Moving Average and Crown Therapeutics Acquires Revance for $924M

Biotech & Healthcare

Jonathan Poyer

Aug 15, 20242 min read

Diving Into the Mortgage and Housing Market - Prices Remain High, Inventory Low, But the Future of Rates Has Investors, Borrowers, and Owners Engaged

Diving Into the Mortgage and Housing Market - Prices Remain High, Inventory Low, But the Future of Rates Has Investors, Borrowers, and Owners Engaged

Diving Into the Mortgage and Housing Market - Prices Remain High, Inventory Low, But the Future of Rates Has Investors, Borrowers, and Owners Engaged

Jonathan Poyer

Aug 8, 20242 min read

A Look at Biotech Earnings Beats and Misses - Overall a Solid Quarter

A Look at Biotech Earnings Beats and Misses - Overall a Solid Quarter

A Look at Biotech Earnings Beats and Misses - Overall a Solid Quarter

Biotech & Healthcare

Jonathan Poyer

Aug 7, 20242 min read

The 10-year Yield Falls with S&P Biotech Index - Trends Breaking and Sector Optimistic

The 10-year Yield Falls with S&P Biotech Index - Trends Breaking and Sector Optimistic

The 10-year Yield Falls with S&P Biotech Index - Trends Breaking and Sector Optimistic

Biotech & Healthcare

Jonathan Poyer

Aug 7, 20242 min read

July 2024 Follow-Up with the Doctor

July 2024 Follow-Up with the Doctor

July 2024 Follow-Up with the Doctor

Dr. is IN Monthly Call Recordings

Jonathan Poyer

Jul 31, 20241 min read

Collegium Acquires Ironshore Therapeutics for $525M and Big Pharma Rallies on Strong Earnings and IRA Policy Impact

Collegium Acquires Ironshore Therapeutics for $525M and Big Pharma Rallies on Strong Earnings and IRA Policy Impact

Collegium Acquires Ironshore Therapeutics for $525M and Big Pharma Rallies on Strong Earnings and IRA Policy Impact

Biotech/Healthcare Weekly Updates

Jonathan Poyer

Jul 31, 20243 min read

There Is Still No Market Volatility! One 2% Up Day and Zero -2% Down Days in Almost a Year

There Is Still No Market Volatility! One 2% Up Day and Zero -2% Down Days in Almost a Year

There Is Still No Market Volatility! One 2% Up Day and Zero -2% Down Days in Almost a Year

Jonathan Poyer

Jul 26, 20242 min read

Breaking Down of Momentum as a Leading Performance Metric Continues to Influence Biotech Sector

Breaking Down of Momentum as a Leading Performance Metric Continues to Influence Biotech Sector

Breaking Down of Momentum as a Leading Performance Metric Continues to Influence Biotech Sector

Biotech & Healthcare

Jonathan Poyer

Jul 24, 20242 min read

Why Are Fixed Income Managers Staring at SOFR Rates and Why Does Their Coming Down Matter?

Why Are Fixed Income Managers Staring at SOFR Rates and Why Does Their Coming Down Matter?

Why Are Fixed Income Managers Staring at SOFR Rates and Why Does Their Coming Down Matter?

Jonathan Poyer

Jul 24, 20242 min read

Illumnia Acquires Fluent Biosciences and CMS Rule Changes Ignite Lantheus Holdings Up +35% As Biotech Continues Its Summer Bump

Illumnia Acquires Fluent Biosciences and CMS Rule Changes Ignite Lantheus Holdings Up +35% As Biotech Continues Its Summer Bump

Illumnia Acquires Fluent Biosciences and CMS Rule Changes Ignite Lantheus Holdings Up +35% As Biotech Continues Its Summer Bump

Biotech & Healthcare

Jonathan Poyer

Jul 16, 20242 min read

July 2024 Riffin' on Real Estate

July 2024 Riffin' on Real Estate

July 2024 Riffin' on Real Estate

Riffin' on Real Estate Recordings

Jonathan Poyer

Jul 16, 20241 min read

bottom of page